No evidence for human papillomavirus infection in focal cortical dysplasia IIb

Annals of Neurology

Volumn 77, Issue 2, 2015, Pages 312-319

  Coras, Roland ^a   Korn, Klaus ^a   Bien, Christian G ^b   Kalbhenn, Thilo ^c   Rössler, Karl ^a   Kobow, Katja ^a   Giedl, Johannes ^a   Fleckenstein, Bernhard ^a   Blumcke, Ingmar ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b EPILEPSY CENTER BETHEL   (Germany)

^c EVANGELISCHES KRANKENHAUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; PROTEIN E6; VIRUS DNA; DNA BINDING PROTEIN; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MULTIPROTEIN COMPLEX; ONCOPROTEIN; TARGET OF RAPAMYCIN KINASE;

ADOLESCENT; ADULT; ANTIGEN ANTIBODY REACTION; ANTIGEN DETECTION; ARTICLE; CARCINOGENESIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FOCAL EPILEPSY; GENE AMPLIFICATION; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALFORMATION OF CORTICAL DEVELOPMENT GROUP II; MALFORMATION OF CORTICAL DEVELOPMENT GROUP IIB; OPEN READING FRAME; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; VIRAL DISEASE IMMUNOFLUORESCENCE ASSAY; VIRUS DETECTION; WESTERN BLOTTING; ISOLATION AND PURIFICATION; MALFORMATIONS OF CORTICAL DEVELOPMENT; PAPILLOMAVIRUS INFECTIONS; PRESCHOOL CHILD; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DNA-BINDING PROTEINS; FEMALE; HUMANS; MALE; MALFORMATIONS OF CORTICAL DEVELOPMENT; MULTIPROTEIN COMPLEXES; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; TOR SERINE-THREONINE KINASES; YOUNG ADULT;

EID: 84922712373     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24328     Document Type: Article

References (32)

1. zur Hausen H. Condylomata acuminata and human genital cancer. Cancer Res 1976;36(2 pt 2):794.
2. zur Hausen H. Papillomaviruses in the causation of human cancers - a brief historical account. Virology 2009;384:260-265.
3. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-527.
4. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990; 248:76-79.
5. Munger K, Werness BA, Dyson N, et al. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J 1989;8:4099-4105.
6. Spangle JM, Munger K. The human papillomavirus type 16 E6 oncoprotein activates mTORC1 signaling and increases protein synthesis. J Virol 2010;84:9398-9407.
7. Aronica E, Becker AJ, Spreafico R. Malformations of cortical development. Brain Pathol 2012;22:380-401.
8. Baybis M, Yu J, Lee A, et al. mTOR cascade activation distinguishes tubers from focal cortical dysplasia. Ann Neurol 2004;56: 478-487.
9. Becker AJ, Urbach H, Scheffler B, et al. Focal cortical dysplasia of Taylor's balloon cell type: mutational analysis of the TSC1 gene indicates a pathogenic relationship to tuberous sclerosis. Ann Neurol 2002;52:29-37.
10. Blumcke I, Spreafico R. An international consensus classification for focal cortical dysplasias. Lancet Neurol 2011;10:26-27.
11. Yasin SA, Ali AM, Tata M, et al. mTOR-dependent abnormalities in autophagy characterize human malformations of cortical development: evidence from focal cortical dysplasia and tuberous sclerosis. Acta Neuropathol 2013;126:207-218.
12. Chen J, Tsai V, Parker WE, et al. Detection of human papillomavirus in human focal cortical dysplasia type IIB. Ann Neurol 2012;72:881-892.
13. Liu S, Lu L, Cheng X, et al. Viral infection and focal cortical dysplasia. Ann Neurol 2014;75:614-616.
14. Blumcke I, Vinters HV, Armstrong D, et al. Malformations of cortical development and epilepsies: neuropathological findings with emphasis on focal cortical dysplasia. Epileptic Disord 2009;11:181-193.
15. Barkovich AJ, Guerrini R, Kuzniecky RI, et al. A developmental and genetic classification for malformations of cortical development: update 2012. Brain 2012;135(pt 5):1348-1369.
16. Guerrini R, Dobyns WB. Malformations of cortical development: clinical features and genetic causes. Lancet Neurol 2014;13:710-726.
17. Blumcke I, Thom M, Aronica E, et al. The clinico-pathological spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc task force of the ILAE Diagnostic Methods Commission. Epilepsia 2011;52:158-174.
18. Barkovich AJ, Kuzniecky RI, Bollen AW, Grant PE. Focal transmantle dysplasia: a specific malformation of cortical development. Neurology 1997;49:1148-1152.
19. Fukui K, Morioka T, Nishio S, et al. Multiple focal cortical dysplasias presenting with intractable epilepsy: case report [in Japanese]. No To Shinkei 2001;53:961-967.
20. Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med 2006;355:1345-1356.
21. Tsai V, Parker WE, Orlova KA, et al. Fetal brain mTOR signaling activation in tuberous sclerosis complex. Cereb Cortex 2014;24:315-327.
22. Prabowo AS, Anink JJ, Lammens M, et al. Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammation. Brain Pathol 2013;23:45-59.
23. Sarnat H, Flores-Sarnat L, Crino P, et al. Hemimegalencephaly: foetal tauopathy with mTOR hyperactivation and neuronal lipidosis. Folia Neuropathol 2012;50:330-345.
24. Baek ST, Gibbs EM, Gleeson JG, Mathern GW. Hemimegalencephaly, a paradigm for somatic postzygotic neurodevelopmental disorders. Curr Opin Neurol 2013;26:122-127.
25. Orlova KA, Tsai V, Baybis M, et al. Early progenitor cell marker expression distinguishes type II from type I focal cortical dysplasias. J Neuropathol Exp Neurol 2010;69:850-863.
26. Wong M. Is focal cortical dysplasia an infectious disease? Epilepsy Curr 2013;13:226-228.
27. Wolf HK, Buslei R, Schmidt Kastner R, et al. NeuN: a useful neuronal marker for diagnostic histopathology. J Histochem Cytochem 1996;44:1167-1171.
28. Klug SJ, Molijn A, Schopp B, et al. Comparison of the performance of different HPV genotyping methods for detecting genital HPV types. J Med Virol 2008;80:1264-1274.
29. Warfvinge K, Edvinsson L. Pearls and pitfalls in neural CGRP immunohistochemistry. Cephalalgia 2013;33:593-603.
30. Braak H. Architectonics of the human telencephalic cortex. Braitenberg V, Barlow HB, Bizzi E, et al, eds. Studies of brain function, vol 4. Berlin, Germany: Springer, 1980:1-147.
31. Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA 2007;297:813-819.
32. Vidone M, Alessandrini F, Marucci G, et al. Evidence of association of human papillomavirus with prognosis worsening in glioblastoma multiforme. Neuro Oncol 2014;16:298-302